neonatal mesenchymal cells (nMSCs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for neonatal mesenchymal cells (nMSCs), covering 2025-09-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM) [Phase 1]